Replies to post #161141 on Cytodyn Inc (CYDY)

[Itchy palm]

I knew they weren’t on the same level as leronlimab just don’t like the false claims being perpetuated here.

[DonDonDonDon]

HGEN's Lenzilumab excluded anyone with an O2 level below 94, so it's not a competitor to Leronlimab.

HGEN chose treating patients when they are transitioning from moderate to becoming severe. It doesn't mean that it wouldn't work at the other stages. But it was pretty smart to treat patients right when cytokine storm is starting. Good trial design. HGEN's management have literally made zero mistakes. They have met every timeline and every promise. They are literally the opposite of CYDY in every aspect.